PROXY STATEMENT

Company

UTAH MEDICAL PRODUCTS INC

Filed

April 13, 2022

Period of Report

April 13, 2022

Accession Number

0001096906-22-000827

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →